Literature DB >> 14567721

Human papillomavirus infection of the epididymis and ductus deferens: an evaluation by nested polymerase chain reaction.

Alexandr Svec1, Iva Mikysková, Ondrej Hes, Ruth Tachezy.   

Abstract

CONTEXT: Human papillomaviruses (HPVs) play an important role in the etiology of squamous cell carcinoma of the uterine cervix. The possible role of the male urogenital tract as a reservoir of HPV infection is not fully understood. We inferred from our previous observation of HPV-31 in epididymal tissue in a case of chronic epididymitis that HPV might be commonly present in cases of epididymitis caused by sexually transmitted pathogens.
OBJECTIVE: To assess the presence of HPV in the epididymis and ductus deferens in nontuberculous epididymitis.
DESIGN: Epididymal samples obtained from 17 patients and epididymal and ductus deferens samples from 5 patients surgically treated for nontuberculous epididymitis were analyzed by nested polymerase chain reaction for the presence of HPV DNA. In positive samples, the HPV type was determined by DNA sequencing.
SETTING: Tertiary-care academic hospital and national reference laboratory for papillomaviruses.
RESULTS: Low-risk HPV type 6 and high-risk HPV types 16, 33, 35, 55, and 73 were detected in 7 patients (31%). Neither koilocytes nor dysplastic changes were found in the epididymis and ductus deferens.
CONCLUSION: Low-risk and high-risk HPV types were detected in the epididymis and ductus deferens of patients with nontuberculous epididymitis. The infection was not accompanied by koilocytic atypia or dysplasia. Our findings support the hypothesis that the male urogenital tract serves as a reservoir of HPV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567721     DOI: 10.5858/2003-127-1471-HPIOTE

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  Investigation of Th1/Th2 cytokine profiles in patients with laryngo-pharyngeal, HPV-positive cancers.

Authors:  Coralia Bleotu; Mariana Carmen Chifiriuc; Raluca Grigore; Camelia Grancea; Cristian R Popescu; Gabriela Anton; Costin Cernescu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-13       Impact factor: 2.503

Review 2.  Human papillomavirus (HPV) infection: a Mozambique overview.

Authors:  Damiano Pizzol; Giovanni Putoto; Kajal D Chhaganlal
Journal:  Virusdisease       Date:  2016-05-03

3.  Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa.

Authors:  Carlo Foresta; Cristina Patassini; Alessandro Bertoldo; Massimo Menegazzo; Felice Francavilla; Luisa Barzon; Alberto Ferlin
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

4.  Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer.

Authors:  Mahdieh Farzanehpour; Sayed-Hamidreza Mozhgani; Somayeh Jalilvand; Ebrahim Faghihloo; Setareh Akhavan; Vahid Salimi; Talat Mokhtari Azad
Journal:  Virol J       Date:  2019-10-07       Impact factor: 4.099

Review 5.  Genetic instability and anti-HPV immune response as drivers of infertility associated with HPV infection.

Authors:  Maria Isaguliants; Stepan Krasnyak; Olga Smirnova; Vincenza Colonna; Oleg Apolikhin; Franco M Buonaguro
Journal:  Infect Agent Cancer       Date:  2021-05-10       Impact factor: 2.965

6.  The prevalence of Human Papilloma Virus (HPV) infection in the oligospermic and azoospermic men.

Authors:  Sherko Nasseri; Seyed Hamidreza Monavari; Hossein Keyvani; Bahram Nikkhoo; Rouhollah Vahabpour Roudsari; Mohammad Khazeni
Journal:  Med J Islam Repub Iran       Date:  2015-10-04

7.  P16INK4A Immunohistochemistry as a Gold Standard for Cervical Cancer and Precursor Lesions Screening.

Authors:  Mahdieh Farzanehpour; Ahad Muhammadnejad; Setareh Akhavan; Amir Nader Emami Razavi; Somayeh Jalilvand; Vahid Salimi; Ebrahim Faghihloo; Ehsan Kakavandi; Mohammad Farahmand; Mohammad Shayestehpour; Farzad Babakhani; Talat Mokhtari Azad
Journal:  Iran J Public Health       Date:  2020-02       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.